Mehdi Gasmi

Mehdi Gasmi has a diverse work experience spanning over several companies and roles. In 1997, they began their career as a Postdoctoral Scientist at Viagene/Chiron Corporation, followed by positions as Scientist II at Cell Genesys and Chiron Corporation. In 2000, they worked as a Scientist at uc.

From 2001 to 2009, Gasmi served as the Sr. Director of Product Development at Ceregene, Inc. Mehdi then joined Genethon in 2009 as the VP of Product Development & Manufacturing. In 2011, they became a Principal at ClinVec Solutions, LLC and held the role until 2013.

Gasmi's extensive tenure at Adverum Biotechnologies, Inc. began in 2013 when they became the Chief Science and Technology Officer and SVP of Pharmaceutical Development. Mehdi went on to serve as the President and Chief Scientific Officer from 2018 to 2019. Additionally, they were a Board Member during their time at the company.

Currently, Gasmi serves as the Chief Operating Officer at SparingVision, a position they started in November 2021.

Mehdi Gasmi completed their education at Université Claude Bernard Lyon 1, where they pursued a Ph.D. in Biochemistry from 1984 to 1996.